Gadolinium-Containing MRI Contrast Agents: Important Variations on a Theme for NSF

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Millions of doses of gadolinium-based contrast agents (GBCAs) are administered annually to improve the clinical utility of magnetic resonance imaging. All the approved agents incorporate one atom of the rare earth metal gadolinium into a chelate to improve the safety of the ordinarily toxic free gadolinium. The undeniable epidemiologic link between GBCAs and nephrogenic systemic fibrosis (NSF) has prompted renewed investigation into the different chemical properties of the GBCAs despite their clinical interchangeability. Gadolinium-based contrast agents can be divided into different categories: linear versus macrocyclic structure, ionic versus nonionic, and non-protein-binding versus protein-binding agents. The GBCAs differ significantly with respect to transmetallation and kinetic and thermodynamic stability and therefore their propensity to release free gadolinium, which is hypothesized to induce NSF. That gadodiamide, with its susceptibility to transmetallation and relatively low thermodynamic and kinetic stability, is associated with the most cases of NSF supports this hypothesis. On the other hand, the greater stability of a macrocyclic agent hypothetically would confer a greater safety margin with regard to NSF. Because few published data on an experimental model of NSF exist, continuing vigilance is necessary to report new cases of NSF, especially with regard to the agents with small market share.

Original languageEnglish (US)
Pages (from-to)29-35
Number of pages7
JournalJournal of the American College of Radiology
Volume5
Issue number1
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Nephrogenic Fibrosing Dermopathy
Gadolinium
Contrast Media
gadodiamide
Thermodynamics
Rare Earth Metals
Safety
Poisons
Protein Binding
Carrier Proteins
Theoretical Models
Magnetic Resonance Imaging

Keywords

  • gadolinium
  • kinetics
  • MRI contrast
  • nephrogenic fibrosing dermopathy
  • Nephrogenic systemic fibrosis
  • thermodynamics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

@article{c67ffb18465743b5a594b59251dbb379,
title = "Gadolinium-Containing MRI Contrast Agents: Important Variations on a Theme for NSF",
abstract = "Millions of doses of gadolinium-based contrast agents (GBCAs) are administered annually to improve the clinical utility of magnetic resonance imaging. All the approved agents incorporate one atom of the rare earth metal gadolinium into a chelate to improve the safety of the ordinarily toxic free gadolinium. The undeniable epidemiologic link between GBCAs and nephrogenic systemic fibrosis (NSF) has prompted renewed investigation into the different chemical properties of the GBCAs despite their clinical interchangeability. Gadolinium-based contrast agents can be divided into different categories: linear versus macrocyclic structure, ionic versus nonionic, and non-protein-binding versus protein-binding agents. The GBCAs differ significantly with respect to transmetallation and kinetic and thermodynamic stability and therefore their propensity to release free gadolinium, which is hypothesized to induce NSF. That gadodiamide, with its susceptibility to transmetallation and relatively low thermodynamic and kinetic stability, is associated with the most cases of NSF supports this hypothesis. On the other hand, the greater stability of a macrocyclic agent hypothetically would confer a greater safety margin with regard to NSF. Because few published data on an experimental model of NSF exist, continuing vigilance is necessary to report new cases of NSF, especially with regard to the agents with small market share.",
keywords = "gadolinium, kinetics, MRI contrast, nephrogenic fibrosing dermopathy, Nephrogenic systemic fibrosis, thermodynamics",
author = "Kuo, {Phillip H}",
year = "2008",
doi = "10.1016/j.jacr.2007.08.014",
language = "English (US)",
volume = "5",
pages = "29--35",
journal = "Journal of the American College of Radiology",
issn = "1558-349X",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Gadolinium-Containing MRI Contrast Agents

T2 - Important Variations on a Theme for NSF

AU - Kuo, Phillip H

PY - 2008

Y1 - 2008

N2 - Millions of doses of gadolinium-based contrast agents (GBCAs) are administered annually to improve the clinical utility of magnetic resonance imaging. All the approved agents incorporate one atom of the rare earth metal gadolinium into a chelate to improve the safety of the ordinarily toxic free gadolinium. The undeniable epidemiologic link between GBCAs and nephrogenic systemic fibrosis (NSF) has prompted renewed investigation into the different chemical properties of the GBCAs despite their clinical interchangeability. Gadolinium-based contrast agents can be divided into different categories: linear versus macrocyclic structure, ionic versus nonionic, and non-protein-binding versus protein-binding agents. The GBCAs differ significantly with respect to transmetallation and kinetic and thermodynamic stability and therefore their propensity to release free gadolinium, which is hypothesized to induce NSF. That gadodiamide, with its susceptibility to transmetallation and relatively low thermodynamic and kinetic stability, is associated with the most cases of NSF supports this hypothesis. On the other hand, the greater stability of a macrocyclic agent hypothetically would confer a greater safety margin with regard to NSF. Because few published data on an experimental model of NSF exist, continuing vigilance is necessary to report new cases of NSF, especially with regard to the agents with small market share.

AB - Millions of doses of gadolinium-based contrast agents (GBCAs) are administered annually to improve the clinical utility of magnetic resonance imaging. All the approved agents incorporate one atom of the rare earth metal gadolinium into a chelate to improve the safety of the ordinarily toxic free gadolinium. The undeniable epidemiologic link between GBCAs and nephrogenic systemic fibrosis (NSF) has prompted renewed investigation into the different chemical properties of the GBCAs despite their clinical interchangeability. Gadolinium-based contrast agents can be divided into different categories: linear versus macrocyclic structure, ionic versus nonionic, and non-protein-binding versus protein-binding agents. The GBCAs differ significantly with respect to transmetallation and kinetic and thermodynamic stability and therefore their propensity to release free gadolinium, which is hypothesized to induce NSF. That gadodiamide, with its susceptibility to transmetallation and relatively low thermodynamic and kinetic stability, is associated with the most cases of NSF supports this hypothesis. On the other hand, the greater stability of a macrocyclic agent hypothetically would confer a greater safety margin with regard to NSF. Because few published data on an experimental model of NSF exist, continuing vigilance is necessary to report new cases of NSF, especially with regard to the agents with small market share.

KW - gadolinium

KW - kinetics

KW - MRI contrast

KW - nephrogenic fibrosing dermopathy

KW - Nephrogenic systemic fibrosis

KW - thermodynamics

UR - http://www.scopus.com/inward/record.url?scp=37549063971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549063971&partnerID=8YFLogxK

U2 - 10.1016/j.jacr.2007.08.014

DO - 10.1016/j.jacr.2007.08.014

M3 - Article

C2 - 18180006

AN - SCOPUS:37549063971

VL - 5

SP - 29

EP - 35

JO - Journal of the American College of Radiology

JF - Journal of the American College of Radiology

SN - 1558-349X

IS - 1

ER -